首页|期刊导航|中国药理学与毒理学杂志|OTUD4对慢性低压低氧所致右心室肥厚的调控作用及机制

OTUD4对慢性低压低氧所致右心室肥厚的调控作用及机制OA

Regulatory roles and mechanisms of OTUD4 in chronic hypobaric hypoxia-induced right ventricular hypertrophy

中文摘要英文摘要

目的 探讨OTU去泛素化酶4(OTUD4)对低压低氧诱导的右心室肥厚(RVH)的调控作用及机制.方法 将野生型(WT)和OTUD4敲除(OTUD4-/-)小鼠根据性别分别随机分为WT对照组、OTUD4-/-对照组、WT模型组和OTUD4-/-模型组,共8组.模型组小鼠饲养于模拟5 500 m海拔的低压低氧舱内连续28 d以建立RVH模型.心脏超声检测三尖瓣环收缩期位移(TAPSE)、右心室游离壁厚度(RVFWT)、肺动脉瓣血流峰值速度(PPVFV);Masson染色检测心肌组织纤维化面积;称量右心室、左心室和室间隔质量以计算RVH指数(RVHI);ELISA法检测血清心钠素(ANP)和肿瘤坏死因子-α(TNF-α)水平;Western印迹法检测OTUD4、低氧诱导因子-1α(HIF-1α)、磷酸化腺苷酸活化蛋白激酶(p-AMPK)、磷酸化真核翻译起始因子4E结合蛋白1(p-4EBP1)及磷酸化哺乳动物雷帕霉素靶蛋白(p-mTOR)表达水平.结果 与WT对照组相比,OTUD4-/-对照组右心室心肌组织OTUD4表达水平显著降低,TAPSE、PPVFV、RVFWT和RVHI,右心室纤维化面积,血清ANP和TNF-α,右心室心肌组织p-AMPK、p-4EBP1、HIF-1α和p-mTOR均无明显差异;WT模型组TAPSE、PPVFV显著降低,RVFWT、RVHI、右心室纤维化面积、血清中ANP和TNF-α显著增加,右心室心肌组织中p-AMPK表达显著降低,OTUD4、p-4EBP1、p-mTOR和HIF-1α表达显著升高.与WT模型组相比,OTUD4-/-模型组小鼠TAPSE、PPVFV显著升高,RVFWT、RVHI、右心室纤维化面积、血清中ANP和TNF-α显著降低,右心室p-AMPK表达显著升高,OTUD4、p-4EBP1、p-mTOR和HIF-1α的表达显著降低.雌雄鼠结果一致.结论 抑制OTUD4可能通过调控AMPK/mTOR/HIF-1α信号通路逆转低压低氧暴露诱导的RVH和右心功能不全.

OBJECTIVE To investigate the regulatory role and mechanism of OTU domain-containing deubiquitinase 4(OTUD4)in simulated hypobaric hypoxia-induced right ventricular hypertrophy(RVH).METHODS Wild-type(WT)and OTUD4 knockout(OTUD4-/-)mice were randomly divided by gender into eight groups:WT control groups,OTUD4-/-control groups,WT model groups,and OTUD4-/-model groups.The model groups were housed in a hypobaric hypoxia chamber simulating an altitude of 5 500 m for 28 consecutive days to establish a model of right ventricular hypertrophy.Cardiac ultrasound was performed to measure tricuspid annular plane systolic excursion(TAPSE),right ventricular free wall thickness(RVFWT),and peak pulmonary valve flow velocity(PPVFV).Masson staining was used to detect the size of fibrosis in myocardial tissues.The right ventricle,left ventricle,and interventricular septum were weighed to calculate the right ventricular hypertrophy index(RVHI).Serum levels of atrial natriuretic peptide(ANP)and tumor necrosis factor alpha(TNF-α)were measured using commercial kits.Western blotting was performed to detect the protein expression levels of OTUD4,hypoxia-induc-ible factor 1α(HIF-1α),phosphorylated AMP-activated protein kinase(p-AMPK),phosphorylated eukaryotic translation initiation factor 4E-binding protein 1(p-4EBP1),and phosphorylated mammalian target of rapamycin(p-mTOR).RESULTS Compared with the WT control group,OTUD4 expression levels in right ventricular myocardial tissues were significantly reduced in the OTUD4-/-control group,but no significant differences were observed in TAPSE,PPVFV,RVFWT,RVHI,sizes of right ventricular fibrosis,serum levels of ANP and TNF-α,or the expression levels of p-AMPK,p-4EBP1,HIF-1α,and p-mTOR in right ventricular myocardial tissues.Compared with the WT control group,TAPSE and PPVFV were significantly decreased,RVFWT,RVHI,sizes of right ventricular fibrosis,and serum ANP and TNF-α levels were significantly increased,p-AMPK expressions in right ventricular myocardial tis-sues were significantly decreased while those of OTUD4,p-4EBP1,p-mTOR,and HIF-1α were signifi-cantly increased in the WT model group.Compared with the WT model group,TAPSE and PPVFV were significantly increased,RVFWT,RVHI,sizes of right ventricular fibrosis,and serum ANP and TNF-α levels were significantly decreased,p-AMPK expressions in the right ventricle were significantly increased,while those of OTUD4,p-4EBP1,p-mTOR,and HIF-1α were significantly decreased in the OTUD4-/-model group.The results were consistent between the male and female mice.CONCLU-SION Inhibition of OTUD4 can reverse right ventricular hypertrophy and right ventricular dysfunction induced by hypobaric hypoxia exposure.This protective effect is accompanied by changes in the expressions of key molecules in the AMPK/mTOR/HIF-1α signaling pathway,suggesting that this path-way may be involved.

卢雪平;李硕;黄雨龙;石英贤;刘坚;耿岩;邓云;张有志

安徽理工大学医学院,安徽 淮南 232001||军事医学研究院,北京 100850||国家安全特需药品全国重点实验室,北京 100039||安徽理工大学第一附属医院,安徽 淮南 232007军事医学研究院,北京 100850||国家安全特需药品全国重点实验室,北京 100039军事医学研究院,北京 100850||国家安全特需药品全国重点实验室,北京 100039军事医学研究院,北京 100850||国家安全特需药品全国重点实验室,北京 100039军事医学研究院,北京 100850||国家安全特需药品全国重点实验室,北京 100039军事医学研究院,北京 100850||国家安全特需药品全国重点实验室,北京 100039安徽理工大学医学院,安徽 淮南 232001||安徽理工大学第一附属医院,安徽 淮南 232007军事医学研究院,北京 100850||国家安全特需药品全国重点实验室,北京 100039

医药卫生

去泛素化肥厚型心肌病高原慢性低压低氧缺氧诱导因子能量代谢

deubiquitinationhypertrophic cardiomyopathyplateauchronic hypobaric hypoxiaHIFenergy metabolism

《中国药理学与毒理学杂志》 2026 (1)

31-39,9

安徽理工大学医学专项培育项目(YZ2023H2C015) Anhui University of Science and Technology Special Cultivation Project(YZ2023H2C015)

10.3867/j.issn.1000-3002.2026.08748

评论